Country for PR: United Kingdom
Contributor: PR Newswire Europe
Thursday, June 25 2020 - 00:01
AsiaNet
PMB-Alcen Announces the Launch of FLASHKNiFE, the FLASH Radiotherapy System Dedicated to Clinical Trials
PEYNIER, France, June 25, 2020 /PRNewswire-AsiaNet / --

PMB, a subsidiary of the ALCEN group, is proud to announce the launch of 
FLASHKNiFE, the FLASH radiotherapy system dedicated to clinical trials. 

There is a long-standing history of FLASH at PMB which started in 2011. A 
prototype LINAC engineered to accelerate electrons in FLASH mode, the Oriatron 
6e, was delivered in 2013 at Lausanne University Hospital (CHUV) and it started 
to deliver pre-clinical results soon after on several animal species (zebra 
fish, mice, cats, pigs...). FLASH proved to be a reproducible effect with a 
striking sparing of normal healthy tissues, while the effects on tumors were 
maintained the same amongst all the tumor models tested. 

In 2019, the treatment of a first patient with FLASH therapy was performed 
successfully at CHUV using our Oriatron 6e technology for a patient with a skin 
refractory lymphoma. This first attempt showed that FLASH therapy was feasible 
and safe, notably due to an effective dose monitoring system (Bourhis et al 
Radiother Oncol 2019). 

This successful and joint experience on FLASH with the CHUV made it possible 
for us to develop FLASHKNiFE, a device specifically designed for FLASH 
radiotherapy. It will be able to administer a high single dose of radiation, 
for clinical applications such as skin cancer treatment and intra-operative 
radiotherapy (IORT). This system consists in an ultra-high dose rate LINAC 
mounted on a mobile base. It combines usability, flexibility and FLASH delivery 
mode, with precise configuration and monitoring. A first clinical prototype 
will soon be installed at the CHUV by PMB. 

Our CEO, M. Marc Delmas, adds:

"We have been working with the pioneers of this fascinating subject, Lausanne 
University Hospital, for several years now. We believe that FLASHKNiFE is a 
breakthrough device in the field and the right tool to develop clinical 
applications and go on writing the history of FLASH radiotherapy."

About PMB

PMB is a human-sized company located near Aix-en-Provence, in the south of 
France, specialized in the design and manufacture of complex particle 
accelerators systems for Medical and Research applications. 

Historically, PMB started with the specialty of assembling dissimilar materials 
such as metals and ceramics. Since the late 2000s, we have developed complex 
systems integrating particle accelerators. Among others, an automated system 
that produces in-house PET radiopharmaceuticals and linear accelerators for 
non-destructive testing (high-energy radiography), and radiotherapy.

Contact: 

flashknife@pmb-alcen.com
+33-(0)-442-531-313 

About ALCEN

ALCEN works in 5 fields: Defense & Security, Energy, Medical & Healthcare, 
Aeronautics and Space, and Large Scientific Instruments.

ALCEN's ambition is to establish an ongoing policy of innovation applied first 
and foremost to its own products and services. 

To do this, we are developing a particularly extensive in-house technological 
base. We work closely with research centers. We systematically transfer 
technological developments and feedback from one field to the others and 
develop our technology in specialist laboratories from a select group of top 
experts. 

Publications

- Maud Jaccard et al., High dose-per-pulse electron beam dosimetry: 
Commissioning of the Oriatron eRT6 prototype linear accelerator for preclinical 
use, Med. Phys. 45 (2), February 2018, https://doi.org/10.1002/mp.12713   

- P. G. Jorge, M. Jaccard, K. Petersson et al., Dosimetric and preparation 
procedures for irradiating biological models with pulsed electron beam at 
ultra-high dose-rate, Radiotherapy and Oncology,  
https://doi.org/10.1016/j.radonc.2019.05.004   

- Vozenin M-C et al, The Advantage of FLASH Radiotherapy Confirmed in Mini-pig 
and Cat-cancer Patients, Clin Cancer Res; 2018, 
https://doi.org/10.1158/1078-0432.CCR-17-3375   

- J. Bourhis, W.J Sozzi, P.G. Jorge et al., Treatment of a first patient with 
FLASH-radiotherapy, Radiotherapy and Oncology, 
https://doi.org/10.1016/j.radonc.2019.06.019 

- Vozenin M-C et al., Biological Benefits of Ultra-high Dose Rate FLASH 
Radiotherapy: Sleeping Beauty Awoken, Clinical Oncology, 
https://doi.org/10.1016/j.clon.2019.04.001   


Video - https://www.youtube.com/watch?v=_DPp7BWSkEU 
Photo - https://mma.prnewswire.com/media/1194007/3D_Device_Image.jpg 
Photo - https://mma.prnewswire.com/media/1193851/FLASHKNiFE.jpg 
Logo - https://mma.prnewswire.com/media/1193852/PMB_Alcen_Logo.jpg   


Source: PMB-Alcen  
Translations

Japanese